# The Effect of Minocycline and N-acetylcysteine for the Treatment of Fibromyalgia

> **NCT04594733** · PHASE1,PHASE2 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 14 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** minocycline (200 mg daily) and NAC (1200 mg daily) followed by placebo
- **DRUG:** Placebo followed by minocycline (200 mg daily) and NAC (1200 mg daily)

## Key facts

- **NCT ID:** NCT04594733
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-06
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04594733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04594733, "The Effect of Minocycline and N-acetylcysteine for the Treatment of Fibromyalgia". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04594733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*